1. Home
  2. Protocols and Guidelines
  3. Upcoming CAP Guidelines

Upcoming CAP Guidelines


The CAP's Pathology and Laboratory Quality Center has several guidelines in various stages of the Guideline Development Process. Learn more about the upcoming evidence-based guidelines that follow the National Academy of Medicine's Guideline Principles.

Evidence-Based Guidelines

ASCO/CAP Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
(Updating 2010 publication)
Determine Scope and Form Panel
ASCP/CAP/ASH Requirements for Laboratory Workup of Lymphoma GuidelineComplete Recommendations
MMR and MSI Testing in Patients Being Considered for Checkpoint Inhibitor TherapyResearch and Review
Collection and Handling of Thoracic Small Biopsy and Cytology Specimens for Ancillary StudiesComplete Recommendations
Diagnostic Testing for Diffuse GliomasResearch and Review
Laboratory Work-up and Initial Diagnosis of Monoclonal GammopathiesResearch and Review
Lower Anogenital Squamous Terminology for HPV-associated Lesions
(Updating 2010 publication)
PD-L1 Lung TumorsDetermine Scope and Form Panel
Quantitative Image Analysis (QIA) of HER2 IHC for Breast CancerReview and Approve
Validating Whole Slide Imaging for Diagnostic Purposes in Pathology
(Updating 2013 publication)
Research and Review

Learn More

Read how we develop evidence-based guidelines and view current guidelines.

Learn about guideline development Right Arrow View current guidelines Right Arrow